U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C26H42NO5.Na
Molecular Weight 471.6051
Optical Activity UNSPECIFIED
Defined Stereocenters 10 / 10
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CHENYLGLYCINE SODIUM

SMILES

[Na+].C[C@H](CCC(=O)NCC([O-])=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

InChI

InChIKey=AAYACJGHNRIFCT-YRJJIGPTSA-M
InChI=1S/C26H43NO5.Na/c1-15(4-7-22(30)27-14-23(31)32)18-5-6-19-24-20(9-11-26(18,19)3)25(2)10-8-17(28)12-16(25)13-21(24)29;/h15-21,24,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32);/q;+1/p-1/t15-,16+,17-,18-,19+,20+,21-,24+,25+,26-;/m1./s1

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
Ursodeoxycholyl lysophosphatidylethanolamide inhibits cholestasis- and hypoxia-induced apoptosis by upregulating antiapoptosis proteins.
2015-02
Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs.
2012-05
Angiotensin II protects primary rat hepatocytes against bile salt-induced apoptosis.
2012
Role of bile salt in regulating Mcl-1 phosphorylation and chemoresistance in hepatocellular carcinoma cells.
2011-04-20
Survivin signaling is regulated through nuclear factor-kappa B pathway during glycochenodeoxycholate-induced hepatocyte apoptosis.
2010-12
Bile acid-induced virulence gene expression of Vibrio parahaemolyticus reveals a novel therapeutic potential for bile acid sequestrants.
2010-10-13
HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology.
2010-09-07
Interpreting metabolomic profiles using unbiased pathway models.
2010-02-26
Calcium-dependent nitric oxide production is involved in the cytoprotective properties of n-acetylcysteine in glycochenodeoxycholic acid-induced cell death in hepatocytes.
2010-01-15
Mitochondrial-driven ubiquinone enhances extracellular calcium-dependent nitric oxide production and reduces glycochenodeoxycholic acid-induced cell death in hepatocytes.
2009-12
Effect of membrane cholesterol on BSEP/Bsep activity: species specificity studies for substrates and inhibitors.
2009-09
Bile acid-induced epidermal growth factor receptor activation in quiescent rat hepatic stellate cells can trigger both proliferation and apoptosis.
2009-08-14
Thermodynamics and structure of inclusion compounds of tauro- and glyco-conjugated bile salts and beta-cyclodextrin.
2009-07-07
Current concepts of mechanisms in drug-induced hepatotoxicity.
2009
Determination of intralumenal individual bile acids by HPLC with charged aerosol detection.
2008-12
Insulin-like growth factor-1 isoforms in rat hepatocytes and cholangiocytes and their involvement in protection against cholestatic injury.
2008-09
Activation of focal adhesion kinase and JNK contributes to the extracellular matrix and cAMP-GEF mediated survival from bile acid induced apoptosis in rat hepatocytes.
2008-08
Effects of bile acids on pancreatic ductal bicarbonate secretion in guinea pig.
2008-08
Cytoprotective effect of tauroursodeoxycholate on hepatocyte apoptosis induced by peroxisome proliferator-activated receptor gamma ligand.
2008-07
Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis.
2008
Complexation of tauro- and glyco-conjugated bile salts with three neutral beta-CDs studied by ACE.
2007-10
Bile salts regulate proliferation and apoptosis of liver cells by modulating the IGF1 system.
2007-07
Structural basis for bile salt inhibition of pancreatic phospholipase A2.
2007-06-01
Taurodeoxycholate modulates apical Cl-/OH- exchange activity in Caco2 cells.
2007-05
Glycochenodeoxycholate (GCDC) inhibits cytokine induced iNOS expression in rat hepatocytes.
2007-03
Hydrophobic bile salts induce hepatocyte shrinkage via NADPH oxidase activation.
2007
Bile acids inhibit interleukin-6 signaling via gp130 receptor-dependent and -independent pathways in rat liver.
2006-11
[Bile salts induce differentiation in cultured human normal esophageal mucosal epithelial cells].
2006-09-12
Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum.
2006-08
Sulfasalazine reduces bile acid induced apoptosis in human hepatoma cells and perfused rat livers.
2006-05
Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione.
2006-04
Determinants of cooperativity and site selectivity in human ileal bile acid binding protein.
2006-01-24
Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholangiocytes via oxidative DNA damage.
2005-12-01
Bile salts inhibit growth and induce apoptosis of culture human normal esophageal mucosal epithelial cells.
2005-11-07
Bile salts inhibit growth and induce apoptosis of human esophageal cancer cell line.
2005-09-07
Reversibility of caspase activation and its role during glycochenodeoxycholate-induced hepatocyte apoptosis.
2005-06-24
Inhibition of hepatocyte growth factor production in human fibroblasts by ursodeoxycholic acid.
2005-04
A nuclear receptor ligand down-regulates cytosolic phospholipase A2 expression to reduce bile acid-induced cyclooxygenase 2 activity in cholangiocytes: implications of anticarcinogenic action of farnesoid X receptor agonists.
2005-03
Expression of macrophage migration inhibitory factor in esophageal squamous cell carcinoma and effects of bile acids and NSAIDs.
2005-01
Vectorial transport of bile salts across MDCK cells expressing both rat Na+-taurocholate cotransporting polypeptide and rat bile salt export pump.
2005-01
Unique inhibition of bile salt-induced apoptosis by lecithins and cytoprotective bile salts in immortalized mouse cholangiocytes.
2003-12
Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation.
2003-09
Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation.
2003-08
Gallium-67 activated charcoal: a new method for preparation of radioactive capsules for colonic transit study.
2003-06
[Release of cytochrome C with the interaction of bilirubin, amyloid beta-peptide and glycochenodeoxycholate from isolated mitochondria].
2003-01-15
The human bile salt export pump: characterization of substrate specificity and identification of inhibitors.
2002-11
Membrane structural changes support the involvement of mitochondria in the bile salt-induced apoptosis of rat hepatocytes.
2002-11
The bcl-2 mRNA expression in GCDC-induced obstructive jaundice in rats and its implication in hepatocellular apoptosis.
2002
Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter.
1998-01
Binding of bile acids by glutathione S-transferases from rat liver.
1986-09
Name Type Language
CHENYLGLYCINE SODIUM
Common Name English
NSC-681056
Preferred Name English
GLYCINE, N-((3.ALPHA.,5.BETA.,7.ALPHA.)-3,7-DIHYDROXY-24-OXOCHOLAN-24-YL)-, SODIUM SALT (1:1)
Systematic Name English
GLYCOCHENODEOXYCHOLIC ACID SODIUM SALT
Common Name English
SODIUM GLYCOCHENODEOXYCHOLATE
Common Name English
SODIUM GLYCYLCHENODEOXYCHOLATE
Common Name English
SODIUM CHENODEOXYCHOLYLGLYCINE
Common Name English
SODIUM GLYCOCHENODESOXYCHOLATE
Common Name English
Code System Code Type Description
NSC
681056
Created by admin on Mon Mar 31 18:09:43 GMT 2025 , Edited by admin on Mon Mar 31 18:09:43 GMT 2025
PRIMARY
CHEBI
87818
Created by admin on Mon Mar 31 18:09:43 GMT 2025 , Edited by admin on Mon Mar 31 18:09:43 GMT 2025
PRIMARY
PUBCHEM
23664011
Created by admin on Mon Mar 31 18:09:43 GMT 2025 , Edited by admin on Mon Mar 31 18:09:43 GMT 2025
PRIMARY
FDA UNII
OK5NH65A9B
Created by admin on Mon Mar 31 18:09:43 GMT 2025 , Edited by admin on Mon Mar 31 18:09:43 GMT 2025
PRIMARY
EPA CompTox
DTXSID201036173
Created by admin on Mon Mar 31 18:09:43 GMT 2025 , Edited by admin on Mon Mar 31 18:09:43 GMT 2025
PRIMARY
CAS
16564-43-5
Created by admin on Mon Mar 31 18:09:43 GMT 2025 , Edited by admin on Mon Mar 31 18:09:43 GMT 2025
PRIMARY